Botta, Cirino
 Distribuzione geografica
Continente #
NA - Nord America 1123
EU - Europa 190
AS - Asia 68
AF - Africa 6
SA - Sud America 1
Totale 1388
Nazione #
US - Stati Uniti d'America 1121
IT - Italia 137
CN - Cina 47
RU - Federazione Russa 13
GB - Regno Unito 8
CZ - Repubblica Ceca 6
DE - Germania 6
HK - Hong Kong 5
ZA - Sudafrica 5
FR - Francia 4
IR - Iran 4
TW - Taiwan 4
UA - Ucraina 3
BG - Bulgaria 2
IE - Irlanda 2
JP - Giappone 2
PL - Polonia 2
RO - Romania 2
AT - Austria 1
BD - Bangladesh 1
BT - Bhutan 1
CA - Canada 1
CL - Cile 1
CR - Costa Rica 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
NL - Olanda 1
NO - Norvegia 1
SA - Arabia Saudita 1
SE - Svezia 1
SG - Singapore 1
TN - Tunisia 1
Totale 1388
Città #
Santa Cruz 216
Fairfield 169
Houston 57
Cambridge 53
Ashburn 48
San Diego 45
Seattle 45
Woodbridge 40
Palermo 37
Petrosino 34
Ann Arbor 30
Wilmington 28
Buffalo 24
Chicago 13
Las Vegas 12
Saint Petersburg 10
Shanghai 9
Catanzaro 8
Clearwater 6
Provo 6
Beijing 5
Brookline 4
Catania 4
Milan 4
Muizenberg 4
Nanjing 4
New York 4
Central District 3
Hangzhou 3
Hartford 3
Herndon 3
Lake Forest 3
Mountain View 3
Rome 3
San Jose 3
Taipei 3
Wuhan 3
Atlanta 2
Auburn 2
Caronia 2
Changsha 2
Chengdu 2
Crugers 2
Dallas 2
Dublin 2
Guangzhou 2
Jacksonville 2
La Grange 2
Lanzhou 2
London 2
Los Angeles 2
Luco dei Marsi 2
Mistretta 2
Moscow 2
Nanchang 2
Plovdiv 2
Providence 2
Scottsdale 2
Scranton 2
Settingiano 2
Alameda 1
Assisi 1
Austin 1
Bogra 1
Bremen 1
Central 1
Changchun 1
Chaoyang 1
Cosenza 1
Denver 1
Edinburgh 1
Elk Grove Village 1
Evanston 1
Frankfurt Am Main 1
Galati 1
Haarlem 1
Heidelberg 1
Henderson 1
Hopkinton 1
Jinan 1
Linköping 1
Linz 1
Liverpool 1
Lodz 1
Lombard 1
Mannheim 1
Mirano 1
Newport Beach 1
Nîmes 1
Pittsburgh 1
Portland 1
Rockwall 1
San Giuliano 1
San José 1
San Mateo 1
Seregno 1
Siena 1
Silverton 1
Singapore 1
Southend 1
Totale 1035
Nome #
Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response, file e3ad8926-d423-da0e-e053-3705fe0a2b96 142
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility, file e3ad8926-e431-da0e-e053-3705fe0a2b96 76
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing, file e3ad8926-f8e1-da0e-e053-3705fe0a2b96 68
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia, file e3ad8926-1e53-da0e-e053-3705fe0a2b96 54
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev), file e3ad8926-e6cf-da0e-e053-3705fe0a2b96 53
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients, file e3ad8926-f32d-da0e-e053-3705fe0a2b96 53
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients, file e3ad8926-fbd0-da0e-e053-3705fe0a2b96 48
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: Do we still need it?, file e3ad8926-c46c-da0e-e053-3705fe0a2b96 45
Myositis/myasthenia after pembrolizumab in a bladder cancer patient with an autoimmunity-associated HLA: Immune–biological evaluation and case report, file e3ad8926-acfd-da0e-e053-3705fe0a2b96 43
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies, file e3ad8927-4c34-da0e-e053-3705fe0a2b96 43
Pharmacokinetics and pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in mice and non-human primates, file e3ad8926-d3af-da0e-e053-3705fe0a2b96 42
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients, file e3ad8926-df77-da0e-e053-3705fe0a2b96 42
Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report, file e3ad8926-be9f-da0e-e053-3705fe0a2b96 41
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma, file e3ad8926-c61d-da0e-e053-3705fe0a2b96 41
Mouse models of multiple myeloma: Technologic platforms and perspectives, file e3ad8926-c61e-da0e-e053-3705fe0a2b96 41
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients, file e3ad8926-b345-da0e-e053-3705fe0a2b96 40
Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens, file e3ad8927-125d-da0e-e053-3705fe0a2b96 40
COVID-19: High-JAKing of the Inflammatory “Flight” by Ruxolitinib to Avoid the Cytokine Storm, file e3ad8926-c129-da0e-e053-3705fe0a2b96 39
OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes, file e3ad8926-e6d1-da0e-e053-3705fe0a2b96 39
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival, file e3ad8926-fa13-da0e-e053-3705fe0a2b96 39
Replacement of miR-155 elicits tumor suppressive activity and antagonizes bortezomib resistance in multiple myeloma, file e3ad8927-03a9-da0e-e053-3705fe0a2b96 39
Influence of the fabrication accuracy of hot-embossed PCL scaffolds on cell growths, file e3ad8927-0530-da0e-e053-3705fe0a2b96 37
Myeloid derived suppressor cells in multiple myeloma: Preclinical research and translational opportunities, file e3ad8926-d803-da0e-e053-3705fe0a2b96 36
Mechanisms of immune evasion in multiple myeloma: Open questions and therapeutic opportunities, file e3ad8926-df23-da0e-e053-3705fe0a2b96 36
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up, file e3ad8926-e0bf-da0e-e053-3705fe0a2b96 36
Tumor infiltration by chemokine receptor 7 (CCR7)+ T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer, file e3ad8926-f1e4-da0e-e053-3705fe0a2b96 36
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response, file e3ad8927-0826-da0e-e053-3705fe0a2b96 35
Target Therapy in Platinum-Refractory/Resistant Ovarian Cancer: From Preclinical Findings to Current Clinical Practice, file e3ad8926-d2d9-da0e-e053-3705fe0a2b96 34
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients, file e3ad8926-fa14-da0e-e053-3705fe0a2b96 22
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection, file e3ad8928-9711-da0e-e053-3705fe0a2b96 14
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach, file fe476190-2ed0-49a6-bb02-113d33d680d5 4
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials, file 0e0fd674-ef32-4778-9ffb-6d59e751b989 3
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?, file e3ad8926-c61b-da0e-e053-3705fe0a2b96 3
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: Italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials, file e3ad8928-d090-da0e-e053-3705fe0a2b96 3
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: Italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials, file e3ad8928-e802-da0e-e053-3705fe0a2b96 3
Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma, file 5f06d20d-4343-4078-a8c3-301833ed7012 2
Could PD-1/PDL1 immune checkpoints be linked to HLA signature?, file e3ad8926-d2da-da0e-e053-3705fe0a2b96 2
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies, file e3ad8926-fa10-da0e-e053-3705fe0a2b96 2
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation, file e3ad8927-092d-da0e-e053-3705fe0a2b96 2
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients, file e3ad8927-125f-da0e-e053-3705fe0a2b96 2
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma, file e3ad8927-852d-da0e-e053-3705fe0a2b96 2
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse, file e3ad8926-a890-da0e-e053-3705fe0a2b96 1
Systemic inlammatory status at baseline predicts bevacizumab beneit in advanced non-small cell lung cancer patients, file e3ad8926-a98a-da0e-e053-3705fe0a2b96 1
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma, file e3ad8926-b184-da0e-e053-3705fe0a2b96 1
Pegylated liposomal doxorubicin in the management of ovarian cancer: A systematic review and metaanalysis of randomized trials, file e3ad8926-b24c-da0e-e053-3705fe0a2b96 1
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study, file e3ad8926-ba01-da0e-e053-3705fe0a2b96 1
Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma, file e3ad8926-bae1-da0e-e053-3705fe0a2b96 1
A 13 mer LNA-i-miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells, file e3ad8926-bdc8-da0e-e053-3705fe0a2b96 1
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials, file e3ad8926-be9a-da0e-e053-3705fe0a2b96 1
Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigation, file e3ad8926-be9e-da0e-e053-3705fe0a2b96 1
Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro, file e3ad8926-bea7-da0e-e053-3705fe0a2b96 1
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab, file e3ad8926-c12b-da0e-e053-3705fe0a2b96 1
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells, file e3ad8926-c12c-da0e-e053-3705fe0a2b96 1
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial, file e3ad8926-c46a-da0e-e053-3705fe0a2b96 1
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in relapsed/refractory patients, file e3ad8926-c61a-da0e-e053-3705fe0a2b96 1
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients, file e3ad8926-c61c-da0e-e053-3705fe0a2b96 1
Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer, file e3ad8926-c84a-da0e-e053-3705fe0a2b96 1
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis, file e3ad8926-d5db-da0e-e053-3705fe0a2b96 1
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo, file e3ad8926-d9a9-da0e-e053-3705fe0a2b96 1
Immunomodulatory activity of microRNAs: Potential implications for multiple myeloma treatment, file e3ad8926-db50-da0e-e053-3705fe0a2b96 1
A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells, file e3ad8926-e05f-da0e-e053-3705fe0a2b96 1
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients, file e3ad8926-e204-da0e-e053-3705fe0a2b96 1
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab, file e3ad8926-e36d-da0e-e053-3705fe0a2b96 1
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination, file e3ad8926-e6cd-da0e-e053-3705fe0a2b96 1
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine, file e3ad8926-e6d2-da0e-e053-3705fe0a2b96 1
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study, file e3ad8926-eb9a-da0e-e053-3705fe0a2b96 1
Immunotherapy of colorectal cancer: New perspectives after a long path, file e3ad8926-ec01-da0e-e053-3705fe0a2b96 1
The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis, file e3ad8926-f5d5-da0e-e053-3705fe0a2b96 1
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials, file e3ad8926-fa0f-da0e-e053-3705fe0a2b96 1
Immunologic characterization of COVID-19 patients with hematological cancer, file e3ad8926-fd9f-da0e-e053-3705fe0a2b96 1
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease, file e3ad8927-06d6-da0e-e053-3705fe0a2b96 1
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma, file e3ad8927-06db-da0e-e053-3705fe0a2b96 1
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts, file e3ad8927-07d5-da0e-e053-3705fe0a2b96 1
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma, file e3ad8927-0f10-da0e-e053-3705fe0a2b96 1
miR-22 suppresses DNA ligase III addiction in multiple myeloma, file e3ad8927-0f11-da0e-e053-3705fe0a2b96 1
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma, file e3ad8927-122d-da0e-e053-3705fe0a2b96 1
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology, file e3ad8927-3e34-da0e-e053-3705fe0a2b96 1
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients, file e3ad8927-4dd2-da0e-e053-3705fe0a2b96 1
Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy, file e3ad8927-74fd-da0e-e053-3705fe0a2b96 1
Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report, file e3ad8927-88fa-da0e-e053-3705fe0a2b96 1
A machine learning model based on tumor and immune biomarkers to predict undetectable MRD and survival outcomes in multiple myeloma, file e3ad8927-9418-da0e-e053-3705fe0a2b96 1
Totale 1422
Categoria #
all - tutte 2475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2475

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021283 0000 00 00 5113264
2021/2022780 42624233 3533 9649 188120089
2022/2023359 2116186114 220 00 0000
Totale 1422